By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BeiGene Co.,Ltd 

No.30 Science Park Road
Zhong-Guan-Cun Life Science Park
Changping District  Beijing    China
Phone: n/a Fax: n/a


SEARCH JOBS

BeiGene is a globally focused biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer.

YEAR FOUNDED:

October 28, 2010

LEADERSHIP:

Founders: Xiaodong Wang, and John Oyler

CEO: John Oyler

CFO: Howard Liang

CMO (Medical): Eric Hedrick

JOBS:

Please click here for BeiGene job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email:
Ownership: Public

Web Site: BeiGene
Employees:
Symbol: BGNE
 



Industry
Pharmaceutical






Company News
BeiGene (BGNE) Approved To Start China Trial Of PD-1 Drug 9/13/2016 8:35:16 AM
Medivation (MDVN) Exec Jumps Ship to Become CMO at BeiGene (BGNE) 8/25/2016 6:52:40 AM
BeiGene (BGNE) OK'd To Test PARP Inhibitor In China 8/19/2016 10:14:43 AM
China's BeiGene (BGNE) Starts Combination Trial For Two Novel Cancer Drugs 7/7/2016 9:09:18 AM
BeiGene Presents Positive Interim Data From Trial Of RAF-Inhibitor 4/19/2016 12:15:39 PM
BeiGene Announces Presentations On BGB-283 And Other Pipeline Agents At The 2016 AACR Annual Meeting 3/17/2016 8:07:15 AM
BeiGene Receives Approval To Initiate Clinical Trials In China With BGB-3111 3/7/2016 9:57:47 AM
BeiGene To Present At Cowen and Company 36th Annual Health Care Conference 3/1/2016 8:27:03 AM
BeiGene Announces Closing Of Its Initial Public Offering 2/9/2016 8:04:06 AM
Week In Review: BeiGene Completes $158 Million IPO In The US 2/8/2016 9:07:47 AM
12345
//-->